I wholeheartedly agree with you poor investor, why...

I wholeheartedly agree with you poor investor, why now?

Shareholders have funded +10 years of research, development, symposiums, collaborations and god knows what else, for what... the asset to be sold off in a fire sale to who? what do they (Halasz, Bart, King, Walton, Gordon, Cross, Eck and the acquirer know that we don’t)?

Why hasn’t more information been provided to shareholders about what Bart has been doing for the last 6 month? From what the Chairman told me some significant laboratory testing work was being done, where is this analysis and results of the antibody testing?

IMHO, this asset is worth many multiples of millions dollars and an opportunity has presented itself to sell it off cheaply for the benefit of others at the detriment of shareholders who have funded these programs. It wouldn’t surprise me if Pharma Hungry is trying to buy the asset, for those who have been around long enough you would know they have unconventional ties directly to the company.

@Osi, how do feel about these shenanigans?